CN1420795A - 采用薄膜组织界面装置在生物膜中制作微孔的设备及方法 - Google Patents
采用薄膜组织界面装置在生物膜中制作微孔的设备及方法 Download PDFInfo
- Publication number
- CN1420795A CN1420795A CN00810514A CN00810514A CN1420795A CN 1420795 A CN1420795 A CN 1420795A CN 00810514 A CN00810514 A CN 00810514A CN 00810514 A CN00810514 A CN 00810514A CN 1420795 A CN1420795 A CN 1420795A
- Authority
- CN
- China
- Prior art keywords
- biomembrane
- micropore
- container
- cohort
- pore
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 219
- 239000010409 thin film Substances 0.000 title claims description 22
- 239000012528 membrane Substances 0.000 title abstract description 5
- 230000004907 flux Effects 0.000 claims abstract description 45
- 239000000126 substance Substances 0.000 claims abstract description 29
- 238000012544 monitoring process Methods 0.000 claims abstract description 27
- 241001465754 Metazoa Species 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims description 159
- 239000010410 layer Substances 0.000 claims description 78
- 239000003814 drug Substances 0.000 claims description 63
- 239000000758 substrate Substances 0.000 claims description 51
- 239000012491 analyte Substances 0.000 claims description 50
- 239000000523 sample Substances 0.000 claims description 49
- 230000008569 process Effects 0.000 claims description 47
- 150000001875 compounds Chemical class 0.000 claims description 43
- 239000011159 matrix material Substances 0.000 claims description 43
- 238000004519 manufacturing process Methods 0.000 claims description 41
- 239000012530 fluid Substances 0.000 claims description 36
- 238000005516 engineering process Methods 0.000 claims description 29
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 28
- 239000004020 conductor Substances 0.000 claims description 26
- 239000010408 film Substances 0.000 claims description 23
- 230000036772 blood pressure Effects 0.000 claims description 22
- 238000010438 heat treatment Methods 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 18
- 238000007650 screen-printing Methods 0.000 claims description 18
- 239000003623 enhancer Substances 0.000 claims description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000000975 dye Substances 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 102000004877 Insulin Human genes 0.000 claims description 14
- 108090001061 Insulin Proteins 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 230000002500 effect on skin Effects 0.000 claims description 14
- 239000000835 fiber Substances 0.000 claims description 14
- 229940125396 insulin Drugs 0.000 claims description 14
- 238000002679 ablation Methods 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 13
- 239000012790 adhesive layer Substances 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 230000007170 pathology Effects 0.000 claims description 12
- 238000007789 sealing Methods 0.000 claims description 12
- 238000009941 weaving Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 208000002193 Pain Diseases 0.000 claims description 10
- 230000005611 electricity Effects 0.000 claims description 10
- 239000004744 fabric Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 230000035699 permeability Effects 0.000 claims description 10
- 230000036407 pain Effects 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 8
- 230000008093 supporting effect Effects 0.000 claims description 8
- 229960005486 vaccine Drugs 0.000 claims description 8
- 238000000608 laser ablation Methods 0.000 claims description 7
- 238000003754 machining Methods 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 7
- 230000005540 biological transmission Effects 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 230000009182 swimming Effects 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims description 5
- 239000013060 biological fluid Substances 0.000 claims description 5
- 238000007747 plating Methods 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 230000000638 stimulation Effects 0.000 claims description 5
- 239000006096 absorbing agent Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 238000005530 etching Methods 0.000 claims description 4
- 239000011888 foil Substances 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000000376 reactant Substances 0.000 claims description 4
- 239000003146 anticoagulant agent Substances 0.000 claims description 3
- 229940127219 anticoagulant drug Drugs 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 239000012744 reinforcing agent Substances 0.000 claims description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 150000002433 hydrophilic molecules Chemical class 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 claims 2
- 230000001965 increasing effect Effects 0.000 abstract description 7
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 127
- 210000001519 tissue Anatomy 0.000 description 65
- 239000011230 binding agent Substances 0.000 description 27
- 230000000694 effects Effects 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 24
- 229940079593 drug Drugs 0.000 description 19
- 238000013461 design Methods 0.000 description 18
- 230000006870 function Effects 0.000 description 14
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 14
- 230000009471 action Effects 0.000 description 13
- 230000008901 benefit Effects 0.000 description 13
- 239000000976 ink Substances 0.000 description 13
- 230000007246 mechanism Effects 0.000 description 12
- 238000003825 pressing Methods 0.000 description 12
- 229910052721 tungsten Inorganic materials 0.000 description 12
- 239000010937 tungsten Substances 0.000 description 12
- 230000002085 persistent effect Effects 0.000 description 11
- 230000004888 barrier function Effects 0.000 description 9
- 238000005520 cutting process Methods 0.000 description 9
- 210000003722 extracellular fluid Anatomy 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 210000002615 epidermis Anatomy 0.000 description 8
- 108091006146 Channels Proteins 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 229920000728 polyester Polymers 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000272525 Anas platyrhynchos Species 0.000 description 6
- 229920001651 Cyanoacrylate Polymers 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 239000007767 bonding agent Substances 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000008595 infiltration Effects 0.000 description 6
- 238000001764 infiltration Methods 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004417 polycarbonate Substances 0.000 description 6
- 229920000515 polycarbonate Polymers 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 229910001080 W alloy Inorganic materials 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000006837 decompression Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 5
- 229960001410 hydromorphone Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000004830 Super Glue Substances 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000002759 woven fabric Substances 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 239000002322 conducting polymer Substances 0.000 description 3
- 229920001940 conductive polymer Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000003698 laser cutting Methods 0.000 description 3
- 150000002632 lipids Chemical group 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000615 nonconductor Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- -1 penetrant Substances 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 238000001259 photo etching Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000004945 silicone rubber Substances 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000011358 absorbing material Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 239000004567 concrete Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 238000001001 laser micro-dissection Methods 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 229940127240 opiate Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012779 reinforcing material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000021317 sensory perception Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000276489 Merlangius merlangus Species 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- 229910001362 Ta alloys Inorganic materials 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- DPSCQKGSAHTWSP-LPVYDGHXSA-N Xanthinin Chemical compound C1C=C(C(CC(C)=O)OC(C)=O)[C@@H](C)C[C@@H]2OC(=O)C(=C)[C@H]21 DPSCQKGSAHTWSP-LPVYDGHXSA-N 0.000 description 1
- DPSCQKGSAHTWSP-VBIBSDQJSA-N Xanthumin Natural products O([C@@H](CC(=O)C)C=1[C@@H](C)C[C@H]2OC(=O)C(=C)[C@H]2CC=1)C(=O)C DPSCQKGSAHTWSP-VBIBSDQJSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000002891 anorexigenic effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940035678 anti-parkinson drug Drugs 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 239000003160 antidiuretic agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000002579 antinauseant Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000005219 brazing Methods 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 210000005178 buccal mucosa Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- AXZAYXJCENRGIM-UHFFFAOYSA-J dipotassium;tetrabromoplatinum(2-) Chemical compound [K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2] AXZAYXJCENRGIM-UHFFFAOYSA-J 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000009760 electrical discharge machining Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000002445 parasympatholytic effect Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229940125422 potassium channel blocker Drugs 0.000 description 1
- 239000003450 potassium channel blocker Substances 0.000 description 1
- 229910001487 potassium perchlorate Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000003368 psychostimulant agent Substances 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000012945 sealing adhesive Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000007391 self-medication Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001975 sympathomimetic effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/20—Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
- A61B17/205—Vaccinating by means of needles or other puncturing devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0047—Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
- A61N1/0416—Anode and cathode
- A61N1/0424—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
- A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B2010/008—Interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00747—Dermatology
- A61B2017/00761—Removing layer of skin tissue, e.g. wrinkles, scars or cancerous tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M2005/3022—Worn on the body, e.g. as patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Electrotherapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
Claims (90)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13805099P | 1999-06-08 | 1999-06-08 | |
US60/138,050 | 1999-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1420795A true CN1420795A (zh) | 2003-05-28 |
CN100402105C CN100402105C (zh) | 2008-07-16 |
Family
ID=22480210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008105146A Expired - Lifetime CN100402105C (zh) | 1999-06-08 | 2000-06-08 | 采用薄膜组织界面装置在生物膜中制作微孔的设备及方法 |
Country Status (14)
Country | Link |
---|---|
US (1) | US6692456B1 (zh) |
EP (4) | EP2168497A3 (zh) |
JP (3) | JP4412874B2 (zh) |
CN (1) | CN100402105C (zh) |
AT (1) | ATE324922T1 (zh) |
AU (1) | AU780752B2 (zh) |
CA (1) | CA2376368C (zh) |
CY (1) | CY1107518T1 (zh) |
DE (1) | DE60027720T2 (zh) |
DK (1) | DK1189660T3 (zh) |
ES (1) | ES2260021T3 (zh) |
PT (1) | PT1189660E (zh) |
WO (1) | WO2000074767A2 (zh) |
ZA (1) | ZA200109966B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100401993C (zh) * | 2003-09-01 | 2008-07-16 | 华克医药科技有限公司 | 从皮肤的着色区消除色素的装置 |
CN101262824B (zh) * | 2005-06-17 | 2011-06-29 | 奥尔蒂治疗学公司 | 透膜体输送系统及其使用方法 |
US8932539B2 (en) | 2009-03-25 | 2015-01-13 | Pathway Genomics Corporation | Saliva sample collection systems |
CN108175762A (zh) * | 2010-09-23 | 2018-06-19 | 莫诺索尔克斯有限公司 | 用于直接在包装表面上形成药用产品的方法和系统 |
CN110997058A (zh) * | 2017-06-28 | 2020-04-10 | 技术研究与创新基金会 | 用于活性剂的受控制的和受监视的经皮给药的装置和方法及其用途 |
CN112584889A (zh) * | 2018-05-30 | 2021-03-30 | 王子元 | 非侵入性转运方法 |
CN112654388A (zh) * | 2018-09-10 | 2021-04-13 | Lts洛曼治疗系统股份公司 | 用于制造微结构的装置和方法 |
Families Citing this family (208)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6517532B1 (en) | 1997-05-15 | 2003-02-11 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US20120150163A1 (en) * | 1997-08-12 | 2012-06-14 | Joseph Neev | Home Use Device and Method for Treating Skin Conditions |
EP1987854A1 (en) | 1998-07-14 | 2008-11-05 | Altea Therapeutics Corporation | Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
US6148232A (en) | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
US6597946B2 (en) | 1998-11-09 | 2003-07-22 | Transpharma Ltd. | Electronic card for transdermal drug delivery and analyte extraction |
US6611706B2 (en) | 1998-11-09 | 2003-08-26 | Transpharma Ltd. | Monopolar and bipolar current application for transdermal drug delivery and analyte extraction |
US20030078499A1 (en) * | 1999-08-12 | 2003-04-24 | Eppstein Jonathan A. | Microporation of tissue for delivery of bioactive agents |
US20040005349A1 (en) * | 2000-05-12 | 2004-01-08 | Joseph Neev | Opto-thermal material modification |
AU2012201079B2 (en) * | 2000-06-01 | 2013-03-28 | Georgetown University | Systems and methods for monitoring health and delivering drugs transdermally |
GB0017999D0 (en) * | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
US20020115960A1 (en) * | 2000-08-24 | 2002-08-22 | Redding Bruce K. | Substance delivery system |
WO2002030301A1 (en) * | 2000-10-13 | 2002-04-18 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
AU2002227447B2 (en) * | 2000-12-28 | 2007-05-10 | Palomar Medical Technologies, Inc. | Method and apparatus for therapeutic EMR treatment of the skin |
DE10102817B4 (de) * | 2001-01-23 | 2006-01-12 | Lts Lohmann Therapie-Systeme Ag | Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen |
KR20040020889A (ko) * | 2001-04-20 | 2004-03-09 | 알자 코포레이션 | 유용한 약물을 갖는 코팅을 포함하는 미세돌출부 어레이 |
US6908448B2 (en) * | 2001-08-24 | 2005-06-21 | Dermisonics, Inc. | Substance delivery device |
CA2499838C (en) * | 2001-09-21 | 2012-12-18 | Biovalve Technologies, Inc. | Gas pressure actuated microneedle arrays, and systems and methods relating to same |
CA2500453A1 (en) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Microneedle with membrane |
US6689100B2 (en) * | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
US6648904B2 (en) * | 2001-11-29 | 2003-11-18 | Palomar Medical Technologies, Inc. | Method and apparatus for controlling the temperature of a surface |
EP1465529A4 (en) * | 2002-01-15 | 2005-04-20 | Bruce K Redding Jr | PORTABLE PORTABLE ACOUSTIC APPLICATOR USED TO INDUCE THE RELEASE OF BIOACTIVE COMPOUNDS BY INTERNAL ORGANS |
US8116860B2 (en) | 2002-03-11 | 2012-02-14 | Altea Therapeutics Corporation | Transdermal porator and patch system and method for using same |
US9918665B2 (en) | 2002-03-11 | 2018-03-20 | Nitto Denko Corporation | Transdermal porator and patch system and method for using same |
AU2003265226A1 (en) * | 2002-03-11 | 2003-12-19 | Altea Therapeutics Corporation | Transdermal drug delivery device, method and use |
AU2003226605A1 (en) * | 2002-04-19 | 2003-11-03 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
US7276058B2 (en) | 2002-06-19 | 2007-10-02 | Palomar Medical Technologies, Inc. | Method and apparatus for treatment of cutaneous and subcutaneous conditions |
US7534241B2 (en) * | 2002-09-23 | 2009-05-19 | Microchips, Inc. | Micro-reservoir osmotic release systems and microtube array device |
DE60336834D1 (de) * | 2002-10-09 | 2011-06-01 | Abbott Diabetes Care Inc | Kraftstoffzufuhrvorrichtung, system und verfahren |
US7399401B2 (en) | 2002-10-09 | 2008-07-15 | Abbott Diabetes Care, Inc. | Methods for use in assessing a flow condition of a fluid |
US7431981B2 (en) * | 2002-11-04 | 2008-10-07 | The Boeing Company | Polymer composite structure reinforced with shape memory alloy and method of manufacturing same |
US20060184189A1 (en) † | 2002-11-15 | 2006-08-17 | Lorin Olson | Cap for a dermal tissue lancing device |
AU2003301111A1 (en) * | 2002-12-20 | 2004-07-22 | Palomar Medical Technologies, Inc. | Apparatus for light treatment of acne and other disorders of follicles |
KR20050098277A (ko) * | 2003-01-29 | 2005-10-11 | 이-필 파마 리미티드 | 위장관 내 약물의 능동 송달 |
US20050058701A1 (en) * | 2003-01-29 | 2005-03-17 | Yossi Gross | Active drug delivery in the gastrointestinal tract |
US20040267240A1 (en) * | 2003-01-29 | 2004-12-30 | Yossi Gross | Active drug delivery in the gastrointestinal tract |
US8323955B1 (en) * | 2003-03-05 | 2012-12-04 | Sandia Corporation | Micromachined patch-clamp apparatus |
DE202004021226U1 (de) * | 2003-03-27 | 2007-07-26 | The General Hospital Corp., Boston | Gerät für die dermatologische Behandlung und fraktionale Oberflächenerneuerung der Haut |
ES2737835T3 (es) | 2003-04-23 | 2020-01-16 | Valeritas Inc | Bomba accionada hidráulicamente para la administración de medicamentos de larga duración |
GB0312552D0 (en) * | 2003-06-02 | 2003-07-09 | Nel Technologies Ltd | Functional therapeutic corporeal and wound dressing heaters |
IL156374A0 (en) | 2003-06-10 | 2004-01-04 | Danenberg Holdings 2000 Ltd N | Method for removing a pigmented section of skin |
US20040267283A1 (en) | 2003-06-25 | 2004-12-30 | Daniela Mavor | Method, device and kit for body decoration |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8016811B2 (en) | 2003-10-24 | 2011-09-13 | Altea Therapeutics Corporation | Method for transdermal delivery of permeant substances |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
MXPA06006041A (es) * | 2003-11-28 | 2007-01-31 | Acrux Dds Pty Ltd | Metodo y sistema para administracion transdermica rapida. |
US20050228313A1 (en) * | 2003-12-04 | 2005-10-13 | University Technologies International Inc. | Fluid sampling, analysis and delivery system |
AU2005232581A1 (en) * | 2004-04-09 | 2005-10-27 | Palomar Medical Technologies, Inc. | Emr treated islets |
US20090069741A1 (en) * | 2004-04-09 | 2009-03-12 | Palomar Medical Technologies, Inc. | Methods And Devices For Fractional Ablation Of Tissue For Substance Delivery |
US8792955B2 (en) * | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9089636B2 (en) * | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
US8989833B2 (en) * | 2004-07-13 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2006127694A2 (en) * | 2004-07-13 | 2006-11-30 | Dexcom, Inc. | Analyte sensor |
US20060024722A1 (en) * | 2004-07-30 | 2006-02-02 | Mark Fischer-Colbrie | Samples for detection of oncofetal fibronectin and uses thereof |
US7055756B2 (en) * | 2004-10-25 | 2006-06-06 | Lexmark International, Inc. | Deposition fabrication using inkjet technology |
US20060095001A1 (en) * | 2004-10-29 | 2006-05-04 | Transcutaneous Technologies Inc. | Electrode and iontophoresis device |
US20060135906A1 (en) * | 2004-11-16 | 2006-06-22 | Akihiko Matsumura | Iontophoretic device and method for administering immune response-enhancing agents and compositions |
US8364228B2 (en) * | 2004-12-09 | 2013-01-29 | Flexible Medical Systems, Llc | Appartus and method for continuous real-time trace biomolecular sampling, analysis, and delivery |
US7850645B2 (en) * | 2005-02-11 | 2010-12-14 | Boston Scientific Scimed, Inc. | Internal medical devices for delivery of therapeutic agent in conjunction with a source of electrical power |
US20060276859A1 (en) * | 2005-06-02 | 2006-12-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Photopatterning of skin |
US8157807B2 (en) * | 2005-06-02 | 2012-04-17 | The Invention Science Fund I, Llc | Skin treatment including patterned light |
ATE555824T1 (de) * | 2005-04-11 | 2012-05-15 | Infotonics Technology Ct Inc | Blutüberwachungssysteme und verfahren dafür |
JP2006296511A (ja) * | 2005-04-15 | 2006-11-02 | Transcutaneous Technologies Inc | 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ |
WO2006111201A1 (en) | 2005-04-18 | 2006-10-26 | Pantec Biosolutions Ag | Laser microporator |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
RU2007146596A (ru) * | 2005-05-19 | 2009-06-27 | И-Пилл Фарма, Лтд. (Il) | Проглатываемое устройство для образования окиси азота в тканях |
US20070032846A1 (en) * | 2005-08-05 | 2007-02-08 | Bran Ferren | Holographic tattoo |
JP2006334164A (ja) * | 2005-06-02 | 2006-12-14 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその制御方法 |
AU2016231468B2 (en) * | 2005-06-17 | 2018-04-05 | Passport Technologies, Inc. | Permeant delivery system and methods for use thereof |
JP2006346368A (ja) * | 2005-06-20 | 2006-12-28 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその製造方法 |
US20070038270A1 (en) * | 2005-07-05 | 2007-02-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Multi step photopatterning of skin |
US20080214952A1 (en) * | 2005-07-11 | 2008-09-04 | Jose Mir | Replaceable Cartridge for Allergy Testing System |
US20090214625A1 (en) * | 2005-07-15 | 2009-08-27 | Mizuo Nakayama | Drug delivery patch |
RU2429028C2 (ru) * | 2005-08-01 | 2011-09-20 | Хок Медикал Текнолоджиз Лтд. | Жидкость, способ и устройство для уничтожения пигментации и рубцовой ткани |
US8295922B2 (en) * | 2005-08-08 | 2012-10-23 | Tti Ellebeau, Inc. | Iontophoresis device |
US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
US20070049910A1 (en) * | 2005-08-08 | 2007-03-01 | Palomar Medical Technologies, Inc. | Eye-safe photocosmetic device |
US20070060860A1 (en) * | 2005-08-18 | 2007-03-15 | Transcutaneous Technologies Inc. | Iontophoresis device |
US20070048362A1 (en) * | 2005-08-29 | 2007-03-01 | Transcutaneous Technologies Inc. | General purpose electrolyte solution composition for iontophoresis |
US20070048340A1 (en) * | 2005-08-31 | 2007-03-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Multi step patterning of a skin surface |
CN101912288A (zh) * | 2005-09-02 | 2010-12-15 | 因特赛尔美国公司 | 经皮递送疫苗和透皮递送药物的装置及其应用 |
JPWO2007029611A1 (ja) * | 2005-09-06 | 2009-03-19 | Tti・エルビュー株式会社 | イオントフォレーシス装置 |
US20070112294A1 (en) * | 2005-09-14 | 2007-05-17 | Transcutaneous Technologies Inc. | Iontophoresis device |
CN101252968A (zh) | 2005-09-15 | 2008-08-27 | Tti优而美株式会社 | 棒式离子电渗疗装置 |
CN101309631A (zh) * | 2005-09-15 | 2008-11-19 | 帕洛玛医疗技术公司 | 皮肤光学表征设备 |
AU2006289888B2 (en) * | 2005-09-16 | 2010-12-02 | Tti Ellebeau, Inc. | Catheter type iontophoresis apparatus |
US20070071807A1 (en) * | 2005-09-28 | 2007-03-29 | Hidero Akiyama | Capsule-type drug-releasing device and capsule-type drug-releasing device system |
JP2009509657A (ja) * | 2005-09-30 | 2009-03-12 | Tti・エルビュー株式会社 | 生体界面への活性物質の送達のイオントフォレーシス装置及び方法 |
US20070135754A1 (en) * | 2005-09-30 | 2007-06-14 | Hidero Akiyama | Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same |
WO2007041322A2 (en) * | 2005-09-30 | 2007-04-12 | Tti Ellebeau, Inc. | Iontophoretic delivery of active agents conjugated to nanoparticles |
US20070232983A1 (en) * | 2005-09-30 | 2007-10-04 | Smith Gregory A | Handheld apparatus to deliver active agents to biological interfaces |
US20070078445A1 (en) * | 2005-09-30 | 2007-04-05 | Curt Malloy | Synchronization apparatus and method for iontophoresis device to deliver active agents to biological interfaces |
CA2623037A1 (en) * | 2005-09-30 | 2007-04-12 | Tti Ellebeau, Inc. | Iontophoresis method and apparatus for systemic delivery of active agents |
US20070078376A1 (en) * | 2005-09-30 | 2007-04-05 | Smith Gregory A | Functionalized microneedles transdermal drug delivery systems, devices, and methods |
US20070083185A1 (en) * | 2005-09-30 | 2007-04-12 | Darrick Carter | Iontophoretic device and method of delivery of active agents to biological interface |
KR20080058438A (ko) * | 2005-09-30 | 2008-06-25 | 티티아이 엘뷰 가부시키가이샤 | 생물학적 계면들로 다중 활성 약제들을 전달하기 위한이온삼투 장치 |
KR20080066712A (ko) * | 2005-09-30 | 2008-07-16 | 티티아이 엘뷰 가부시키가이샤 | 관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법 |
US8372806B2 (en) | 2005-10-06 | 2013-02-12 | Pantec Biosolutions Ag | Transdermal delivery system for treating infertility |
US20070197955A1 (en) * | 2005-10-12 | 2007-08-23 | Transcutaneous Technologies Inc. | Mucous membrane adhesion-type iontophoresis device |
CN101331392B (zh) * | 2005-11-02 | 2012-08-08 | 梅-鲁宾科技公司 | 用于产生电场的高阻抗系统及所使用的方法 |
US8226811B2 (en) * | 2005-11-02 | 2012-07-24 | May-Ruben Technologies, Inc. | High impedance system for generating electric fields and method of use |
US7963917B2 (en) * | 2005-12-05 | 2011-06-21 | Echo Therapeutics, Inc. | System and method for continuous non-invasive glucose monitoring |
WO2007079116A1 (en) * | 2005-12-28 | 2007-07-12 | Tti Ellebeau, Inc. | Electroosmotic pump apparatus and method to deliver active agents to biological interfaces |
US20080033398A1 (en) * | 2005-12-29 | 2008-02-07 | Transcutaneous Technologies Inc. | Device and method for enhancing immune response by electrical stimulation |
US7848801B2 (en) * | 2005-12-30 | 2010-12-07 | Tti Ellebeau, Inc. | Iontophoretic systems, devices, and methods of delivery of active agents to biological interface |
WO2007079189A2 (en) * | 2005-12-30 | 2007-07-12 | Tti Ellebeau, Inc. | System and method for remote based control of an iontophoresis device |
US8419708B2 (en) | 2006-02-10 | 2013-04-16 | Hisamitsu Pharmaceuticals Co., Inc. | Transdermal drug administration apparatus having microneedles |
SG173319A1 (en) | 2006-03-30 | 2011-08-29 | Valeritas Inc | Multi-cartridge fluid delivery device |
WO2007123707A1 (en) * | 2006-03-30 | 2007-11-01 | Tti Ellebeau, Inc. | Controlled release membrane and methods of use |
WO2007127339A2 (en) * | 2006-04-26 | 2007-11-08 | Tyco Healthcare Group Lp | Multi-stage microporation device |
EP2035074A4 (en) * | 2006-06-30 | 2012-11-07 | Cvdevices Llc | PERCUTANEOUS INTRAVASCULAR ACCESS TO CARDIAC TISSUE |
WO2008005458A2 (en) * | 2006-07-05 | 2008-01-10 | Tti Ellebeau, Inc. | Delivery device having self-assembling dendritic polymers and method of use thereof |
US20100100005A1 (en) * | 2006-07-11 | 2010-04-22 | Infotonics Technology Center, Inc. | Minimally invasive allergy testing system with coated allergens |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
WO2008027440A2 (en) * | 2006-08-29 | 2008-03-06 | Tti Ellebeau, Inc. | An iontophoresis device and method for operation with a usb (universal serial bus) power source |
US20080114282A1 (en) * | 2006-09-05 | 2008-05-15 | Transcu Ltd. | Transdermal drug delivery systems, devices, and methods using inductive power supplies |
JP2010502954A (ja) * | 2006-09-05 | 2010-01-28 | Tti・エルビュー株式会社 | 化合物のイオントフォレーシス特性を評価するためのインピーダンスシステム、装置及び方法 |
BRPI0716452A2 (pt) * | 2006-09-05 | 2014-03-04 | Tti Ellebeau Inc | Sistemas não destrutivos, dispositivos, e métodos para avaliar dispositivos de distribuição de medicamentos de iontoforese |
US20100298764A1 (en) * | 2006-09-06 | 2010-11-25 | Ofer Yodfat | Fluid delivery system with optical sensing of analyte concentration levels |
US20100004582A1 (en) * | 2006-10-25 | 2010-01-07 | Pantec Biosolutions Ag | Wide-Area Parasystemic Treatment of Skin Related Conditions |
US7842006B2 (en) * | 2006-11-17 | 2010-11-30 | Cfd Research Corporation | Thrombectomy microcatheter |
EP2061551A2 (en) | 2006-12-01 | 2009-05-27 | TTI ellebeau, Inc. | Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
WO2008083305A2 (en) * | 2006-12-29 | 2008-07-10 | Palomar Medical Technologies, Inc. | Devices for fractional ablation of tissue |
WO2008087884A1 (ja) * | 2007-01-16 | 2008-07-24 | Tti Ellebeau, Inc. | 薬物投与量の予測方法及びそのプログラム |
EP3210646B1 (en) | 2007-01-22 | 2023-04-19 | PassPort Technologies, Inc. | Transdermal permeant delivery system |
US7713196B2 (en) * | 2007-03-09 | 2010-05-11 | Nellcor Puritan Bennett Llc | Method for evaluating skin hydration and fluid compartmentalization |
US20080228056A1 (en) | 2007-03-13 | 2008-09-18 | Michael Blomquist | Basal rate testing using frequent blood glucose input |
WO2008115224A2 (en) * | 2007-03-20 | 2008-09-25 | Bayer Healthcare Llc | Method of analyzing an analyte |
US20100121259A1 (en) | 2007-03-29 | 2010-05-13 | Yacov Lutski | Device and system for skin treatment |
NZ582049A (en) * | 2007-05-18 | 2012-12-21 | Tti Ellebeau Inc | Transdermal delivery devices assuring an improved release of an active principle through a biological interface |
US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
US8221345B2 (en) | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
JP2010187707A (ja) * | 2007-06-12 | 2010-09-02 | Hokkaido Univ | インスリンを封入したイオントフォレーシス用リポソーム製剤 |
US20090012446A1 (en) * | 2007-07-03 | 2009-01-08 | Xinyan Cui | Devices, systems and methods for release of chemical agents |
US8328720B2 (en) * | 2007-08-10 | 2012-12-11 | Infotonics Technology Center, Inc. | MEMS interstitial prothrombin time test |
EP2200666B1 (en) * | 2007-10-09 | 2014-12-03 | Syneron Medical Ltd. | Magnetic patch coupling |
EP2205967B1 (en) * | 2007-10-17 | 2013-05-01 | Syneron Medical Ltd. | Dissolution rate verification |
US8500697B2 (en) | 2007-10-19 | 2013-08-06 | Pressure Products Medical Supplies, Inc. | Transseptal guidewire |
WO2009052866A1 (en) * | 2007-10-25 | 2009-04-30 | Pantec Biosolutions Ag | Laser device and method for ablating biological tissue |
US20100293807A1 (en) * | 2007-10-29 | 2010-11-25 | Transpharma Medical, Ltd. | Vertical patch drying |
KR101287351B1 (ko) | 2007-12-05 | 2013-07-23 | 시네론 메디컬 리미티드 | 피부 치료장치용 캐리어 |
CN101970030B (zh) * | 2007-12-17 | 2014-04-16 | 新世界药品有限公司 | 整合的真皮内递送、诊断和通讯系统 |
US7963947B2 (en) * | 2008-01-16 | 2011-06-21 | Pressure Products Medical Supplies, Inc. | Apparatus, system, and method of shielding the sharp tip of a transseptal guidewire |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
CN105126241B (zh) * | 2008-03-31 | 2018-12-25 | 日东电工株式会社 | 透膜物递送系统及其使用方法 |
EP2307546A1 (en) * | 2008-06-04 | 2011-04-13 | Coda Therapeutics, Inc. | Treatment of pain with gap junction modulation compounds |
US8834446B2 (en) * | 2008-06-12 | 2014-09-16 | DePuy Synthes Products, LLC | Pulsatile flux drug delivery |
DE102008002520A1 (de) * | 2008-06-19 | 2009-12-24 | Robert Bosch Gmbh | Vorrichtung zur Bestimmung und/oder Überwachung des Flüssigkeitsgehalts der Haut |
CN105902482A (zh) | 2008-06-25 | 2016-08-31 | Fe3医学有限公司 | 用于经皮递送治疗有效量的铁的贴片和方法 |
US8404255B2 (en) * | 2008-07-29 | 2013-03-26 | Matt Gibson | System and method for transdermal drug delivery |
CA2964564C (en) | 2008-08-21 | 2019-10-22 | Ninepoint Medical, Inc. | Device for drug evaluation and local treatment |
WO2010030738A2 (en) * | 2008-09-10 | 2010-03-18 | Transcu Ltd. | Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
US8650937B2 (en) | 2008-09-19 | 2014-02-18 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
US8606366B2 (en) | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
US8821945B2 (en) * | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
US20100286628A1 (en) * | 2009-05-07 | 2010-11-11 | Rainbow Medical Ltd | Gastric anchor |
US20110066175A1 (en) * | 2009-05-07 | 2011-03-17 | Rainbow Medical Ltd. | Gastric anchor |
US20100286587A1 (en) * | 2009-05-07 | 2010-11-11 | Yossi Gross | Sublingual electrical drug delivery |
US8414559B2 (en) * | 2009-05-07 | 2013-04-09 | Rainbow Medical Ltd. | Gastroretentive duodenal pill |
WO2010144424A2 (en) * | 2009-06-09 | 2010-12-16 | Tti Ellebeau, Inc. | Long life high capacity electrode, device, and method of manufacture |
US9919168B2 (en) | 2009-07-23 | 2018-03-20 | Palomar Medical Technologies, Inc. | Method for improvement of cellulite appearance |
US8641671B2 (en) | 2009-07-30 | 2014-02-04 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
JP5406646B2 (ja) * | 2009-09-16 | 2014-02-05 | シスメックス株式会社 | 組織液収集方法に用いる組織液収集キット及び組織液収集シート |
EP2482724A2 (en) | 2009-09-30 | 2012-08-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
SG170622A1 (en) * | 2009-10-09 | 2011-05-30 | Nitto Denko Corp | A passive drug delivery device and a method of drug delivery |
FR2955024B1 (fr) * | 2010-01-14 | 2012-02-10 | Commissariat Energie Atomique | Dispositif de mise en contact transitoire d'au moins une unite de capture de cibles biologiques avec un fluide les contenant, et procede de recuperation des cibles capturees |
WO2011109491A2 (en) * | 2010-03-03 | 2011-09-09 | Lumenis Ltd. | System and methods of tissue microablation using fractional treatment patterns |
WO2011115328A1 (ko) * | 2010-03-16 | 2011-09-22 | 서울대학교 산학협력단 | 마이크로젯 약물 전달 시스템 |
US9327105B2 (en) | 2010-03-26 | 2016-05-03 | Itrace Biomedical Inc. | Active transdermal drug delivery system and the method thereof |
US9604039B2 (en) * | 2010-06-18 | 2017-03-28 | The Regents Of The University Of California | Unobstructing microdevices for self-clearing implantable catheters |
EP2438938A1 (en) * | 2010-10-11 | 2012-04-11 | PharmaSens AG | Syringe type pump |
US10707570B1 (en) * | 2010-11-22 | 2020-07-07 | Ncap Licensing, Llc | Techniques for pain relief |
US10244981B2 (en) * | 2011-03-30 | 2019-04-02 | SensiVida Medical Technologies, Inc. | Skin test image analysis apparatuses and methods thereof |
WO2012178156A2 (en) * | 2011-06-24 | 2012-12-27 | University Of Miami | Laser assisted delivery of functional cells, peptides and nucleotides |
US9700245B2 (en) * | 2011-09-23 | 2017-07-11 | Itrace Biomedical Inc. | Transdermal analyte extraction and detection system and the method thereof |
US20150005595A1 (en) | 2011-12-30 | 2015-01-01 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
AU2012362318B2 (en) | 2011-12-30 | 2015-09-17 | Kibur Medical, Inc. | Implantable devices and methods for the evaluation of active agent |
CN104736709A (zh) | 2012-03-27 | 2015-06-24 | 科达治疗公司 | 基于钙粘蛋白调节的组合物和治疗 |
KR102342629B1 (ko) | 2012-04-18 | 2021-12-22 | 싸이노슈어, 엘엘씨 | 피코초 레이저 장치 및 그를 사용한 표적 조직의 치료 방법 |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
CA2873881A1 (en) | 2012-05-18 | 2013-11-21 | Stephen Bruce Fleming | Combination treatments and compositions for wound healing |
US20140107450A1 (en) | 2012-10-12 | 2014-04-17 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
US20140213866A1 (en) | 2012-10-12 | 2014-07-31 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
US10179239B2 (en) | 2013-01-15 | 2019-01-15 | Itrace Biomedical Inc. | Personalized pain management treatments |
US9710607B2 (en) * | 2013-01-15 | 2017-07-18 | Itrace Biomedical Inc. | Portable electronic therapy device and the method thereof |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US10285757B2 (en) | 2013-03-15 | 2019-05-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US9603995B2 (en) | 2013-03-15 | 2017-03-28 | Tandem Diabetes Care. Inc. | Device and method for setting therapeutic parameters for an infusion device |
CA2916183C (en) * | 2013-07-03 | 2022-03-29 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with electronic component |
US10413359B2 (en) * | 2013-07-18 | 2019-09-17 | International Business Machines Corporation | Laser-assisted transdermal delivery of nanoparticulates and hydrogels |
US9341639B2 (en) | 2013-07-26 | 2016-05-17 | Industrial Technology Research Institute | Apparatus for microfluid detection |
US20150289788A1 (en) | 2014-04-10 | 2015-10-15 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
EP3145504B1 (en) | 2014-05-20 | 2023-07-26 | LTS Lohmann Therapie-Systeme AG | Transdermal delivery system including an interface mediator |
ES2924899T3 (es) | 2014-05-20 | 2022-10-11 | Lts Lohmann Therapie Systeme Ag | Sistema de administración transdérmica que contiene rotigotina |
US11426359B2 (en) | 2014-05-20 | 2022-08-30 | Lts Lohmann Therapie-Systeme Ag | Method for adjusting the release of active agent in a transdermal delivery system |
JP2018520817A (ja) | 2015-05-15 | 2018-08-02 | クリアイット エルエルシーClearit, Llc | 低温プラズマを用いたタトゥー除去システムおよび方法 |
EP3439730A4 (en) * | 2016-04-06 | 2019-12-25 | Mupharma Pty Ltd | SOUND WAVE-MEDIATED NON-INVASIVE MEDICINE DELIVERY |
EP3338853A1 (en) * | 2016-12-23 | 2018-06-27 | Sanofi-Aventis Deutschland GmbH | Medicament delivery device |
JP6842059B2 (ja) * | 2017-01-11 | 2021-03-17 | 帝人フロンティア株式会社 | 圧電構造体及びそれを用いたデバイス |
EP3609686A4 (en) * | 2017-04-12 | 2020-09-09 | The Government of the United States of America, as represented by the Secretary of the Navy | TEMPERATURE CONTROLLED ELECTRIC SPINNING SUBSTRATE |
US11418000B2 (en) | 2018-02-26 | 2022-08-16 | Cynosure, Llc | Q-switched cavity dumped sub-nanosecond laser |
JP2022514758A (ja) | 2018-12-19 | 2022-02-15 | クリアイット エルエルシー | 印加電場を用いた入れ墨除去システム及び方法 |
US11969576B2 (en) | 2019-07-03 | 2024-04-30 | Tandem Diabetes Care, Inc. | Methods of incorporating CGM data into diabetes therapy |
CN110664439B (zh) * | 2019-09-05 | 2021-07-27 | 华中科技大学 | 一种可提取皮肤组织液的微针及其制备方法 |
US11654236B2 (en) | 2019-11-22 | 2023-05-23 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery for diabetes therapy |
WO2024080052A1 (ja) * | 2022-10-12 | 2024-04-18 | ヤーマン株式会社 | 肌処理装置及び導電シート |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5224928A (en) * | 1983-08-18 | 1993-07-06 | Drug Delivery Systems Inc. | Mounting system for transdermal drug applicator |
US4775361A (en) | 1986-04-10 | 1988-10-04 | The General Hospital Corporation | Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport |
US5380272A (en) * | 1993-01-28 | 1995-01-10 | Scientific Innovations Ltd. | Transcutaneous drug delivery applicator |
US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
EP0781150B1 (en) * | 1995-07-25 | 2002-11-06 | Massachusetts Institute Of Technology | Enhanced transdermal transport using ultrasound |
CN1174713C (zh) * | 1995-08-29 | 2004-11-10 | 光谱股份有限公司 | 用于输药及检测的人体皮肤微穿孔设备 |
WO1998000194A2 (en) * | 1996-06-28 | 1998-01-08 | Sontra Medical, L.P. | Ultrasound enhancement of transdermal transport |
WO1998000193A1 (en) * | 1996-07-03 | 1998-01-08 | Altea Technologies, Inc. | Multiple mechanical microporation of skin or mucosa |
DK0957972T3 (da) * | 1996-12-20 | 2003-07-21 | Alza Corp | Anordning og fremgangsmåde til at forøge transdermal middelflux |
EP1314400B1 (en) | 1996-12-31 | 2007-06-20 | Altea Therapeutics Corporation | Microporation of tissue for delivery of bioactive agents |
EP1037686B1 (en) * | 1997-12-11 | 2005-08-17 | Alza Corporation | Device for enhancing transdermal agent flux |
ATE221400T1 (de) * | 1997-12-11 | 2002-08-15 | Alza Corp | Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses |
ATE375752T1 (de) | 1998-03-06 | 2007-11-15 | Spectrx Inc | Integrierte gewebeporations-, flüssigkeitsammel- und analysevorrichtung |
US6022316A (en) * | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
US6173202B1 (en) * | 1998-03-06 | 2001-01-09 | Spectrx, Inc. | Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
EP1987854A1 (en) | 1998-07-14 | 2008-11-05 | Altea Therapeutics Corporation | Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
ATE380501T1 (de) | 1998-07-21 | 2007-12-15 | Spectrx Inc | Verfahren und vorrichtung zur kontinuierlichen überwachung eines analyten |
AU770388B2 (en) | 1998-07-21 | 2004-02-19 | Altea Therapeutics Corporation | Fluid management in a continuous fluid collection and sensor device |
CA2343762A1 (en) | 1998-09-10 | 2000-03-23 | Spectrx, Inc. | Attribute compensation for analyte detection and/or continuous monitoring |
US6148232A (en) * | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
US6251083B1 (en) * | 1999-09-07 | 2001-06-26 | Amira Medical | Interstitial fluid methods and devices for determination of an analyte in the body |
-
2000
- 2000-06-08 AT AT00939765T patent/ATE324922T1/de active
- 2000-06-08 EP EP09015859A patent/EP2168497A3/en not_active Withdrawn
- 2000-06-08 EP EP05028332A patent/EP1645305A1/en not_active Withdrawn
- 2000-06-08 WO PCT/US2000/015979 patent/WO2000074767A2/en active IP Right Grant
- 2000-06-08 ES ES00939765T patent/ES2260021T3/es not_active Expired - Lifetime
- 2000-06-08 EP EP00939765A patent/EP1189660B1/en not_active Expired - Lifetime
- 2000-06-08 CN CNB008105146A patent/CN100402105C/zh not_active Expired - Lifetime
- 2000-06-08 JP JP2001501298A patent/JP4412874B2/ja not_active Expired - Lifetime
- 2000-06-08 PT PT00939765T patent/PT1189660E/pt unknown
- 2000-06-08 US US09/590,787 patent/US6692456B1/en not_active Expired - Lifetime
- 2000-06-08 CA CA002376368A patent/CA2376368C/en not_active Expired - Lifetime
- 2000-06-08 AU AU54799/00A patent/AU780752B2/en not_active Ceased
- 2000-06-08 DK DK00939765T patent/DK1189660T3/da active
- 2000-06-08 DE DE60027720T patent/DE60027720T2/de not_active Expired - Lifetime
- 2000-06-08 EP EP10012388A patent/EP2286868A3/en not_active Withdrawn
-
2001
- 2001-12-04 ZA ZA200109966A patent/ZA200109966B/en unknown
-
2006
- 2006-07-21 CY CY20061101018T patent/CY1107518T1/el unknown
-
2009
- 2009-02-24 JP JP2009041516A patent/JP2009148588A/ja not_active Withdrawn
-
2010
- 2010-03-29 JP JP2010076330A patent/JP5460419B2/ja not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100401993C (zh) * | 2003-09-01 | 2008-07-16 | 华克医药科技有限公司 | 从皮肤的着色区消除色素的装置 |
CN101262824B (zh) * | 2005-06-17 | 2011-06-29 | 奥尔蒂治疗学公司 | 透膜体输送系统及其使用方法 |
US8932539B2 (en) | 2009-03-25 | 2015-01-13 | Pathway Genomics Corporation | Saliva sample collection systems |
CN108175762A (zh) * | 2010-09-23 | 2018-06-19 | 莫诺索尔克斯有限公司 | 用于直接在包装表面上形成药用产品的方法和系统 |
CN110997058A (zh) * | 2017-06-28 | 2020-04-10 | 技术研究与创新基金会 | 用于活性剂的受控制的和受监视的经皮给药的装置和方法及其用途 |
CN110997058B (zh) * | 2017-06-28 | 2023-10-27 | 技术研究与创新基金会 | 用于活性剂的受控制的和受监视的经皮给药的装置 |
CN112584889A (zh) * | 2018-05-30 | 2021-03-30 | 王子元 | 非侵入性转运方法 |
CN112654388A (zh) * | 2018-09-10 | 2021-04-13 | Lts洛曼治疗系统股份公司 | 用于制造微结构的装置和方法 |
Also Published As
Publication number | Publication date |
---|---|
ES2260021T3 (es) | 2006-11-01 |
DK1189660T3 (da) | 2006-08-21 |
JP2010158554A (ja) | 2010-07-22 |
CN100402105C (zh) | 2008-07-16 |
DE60027720T2 (de) | 2007-04-26 |
CY1107518T1 (el) | 2013-03-13 |
CA2376368C (en) | 2009-08-11 |
WO2000074767A2 (en) | 2000-12-14 |
PT1189660E (pt) | 2006-09-29 |
ATE324922T1 (de) | 2006-06-15 |
DE60027720D1 (de) | 2006-06-08 |
EP2168497A3 (en) | 2010-12-01 |
EP2286868A2 (en) | 2011-02-23 |
AU5479900A (en) | 2000-12-28 |
JP2009148588A (ja) | 2009-07-09 |
EP2286868A3 (en) | 2012-05-16 |
JP5460419B2 (ja) | 2014-04-02 |
AU780752B2 (en) | 2005-04-14 |
JP4412874B2 (ja) | 2010-02-10 |
EP1189660A2 (en) | 2002-03-27 |
WO2000074767A3 (en) | 2001-07-05 |
CA2376368A1 (en) | 2000-12-14 |
EP1645305A1 (en) | 2006-04-12 |
US6692456B1 (en) | 2004-02-17 |
EP1189660B1 (en) | 2006-05-03 |
EP2168497A2 (en) | 2010-03-31 |
JP2004505652A (ja) | 2004-02-26 |
ZA200109966B (en) | 2006-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1420795A (zh) | 采用薄膜组织界面装置在生物膜中制作微孔的设备及方法 | |
US9486616B2 (en) | Transdermal integrated actuator device, methods of making and using same | |
Daugimont et al. | Hollow microneedle arrays for intradermal drug delivery and DNA electroporation | |
AU759738B2 (en) | Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport | |
US20020099356A1 (en) | Transmembrane transport apparatus and method | |
US20190201675A1 (en) | Electromolded microneedles and fabrication methods thereof | |
CN101711130A (zh) | 形成多个微导管的方法和装置 | |
CN1691969A (zh) | 微针装置和微针施用设备 | |
RU2006117783A (ru) | Способ чрескожной доставки проникающих веществ | |
CN107913459A (zh) | 一种液体定量输送装置 | |
Davis | Hollow microneedles for molecular transport across skin | |
Choi et al. | A polymeric electroporation microneedle array for enhanced intracellular delivery | |
JP2004073689A (ja) | 注射針 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: MIDEKAPU FUND III LLC Free format text: FORMER OWNER: ALTEA TECHNOLOGIES, INC. Effective date: 20140504 Owner name: NITTO DENKO CORP. Free format text: FORMER OWNER: MIDEKAPU FUND III LLC Effective date: 20140504 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140504 Address after: American Maryland Patentee after: Mead Karp foundation III LLC Address before: Georgia Patentee before: Altea Therapeutics Corp. Effective date of registration: 20140504 Address after: Osaka Japan Patentee after: Nitto Denko Corp. Address before: American Maryland Patentee before: Mead Karp foundation III LLC |
|
TR01 | Transfer of patent right |
Effective date of registration: 20200102 Address after: California, USA Patentee after: Passport technology Co. Address before: Osaka Japan Patentee before: NITTO DENKO Corp. |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20080716 |
|
CX01 | Expiry of patent term |